Kinderwunsch und Hormon Zentrum an der Oper
Kinderwunsch und Hormon Zentrum an der Oper is a private Munich fertility clinic operated as a five-physician partnership, offering diagnostics, IVF, ICSI, IUI, social freezing, and AI-assisted embryo selection to heterosexual couples, lesbian couples, and single women under GKV, PKV, and self-pay models.
- Company typePrivate
- Founded-
- HeadquartersMunich, Germany
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Kinderwunsch und Hormon Zentrum an der Oper does
Kinderwunsch und Hormon Zentrum an der Oper is a private medical fertility center legally organized as the physician partnership Lacher Puchta Pauer Michna PartG, operating from a single clinical site at Maximilianstrasse 2a, Munich. The practice serves heterosexual couples, lesbian couples, and single women seeking fertility diagnostics and treatment, with services spanning hormone diagnostics, sperm analysis (spermiogram), AMH testing, HyCoSy tubal patency assessment, intrauterine insemination (IUI), IVF, ICSI, blastocyst transfer, assisted hatching, social freezing/egg cryopreservation, and natural messenger-substance hormone therapy. The clinic accepts both statutory (GKV) and private (PKV) insured patients as well as self-pay patients, and notably does not require a guarantor person for single women — a differentiator under the German reproductive-medicine regulatory framework.
The center's technical infrastructure centers on an in-house certified hormone laboratory with external quality assurance, alongside advanced reproductive-medicine devices including the EmbryoScope time-lapse incubator (imaging every 15 minutes for 120 hours), the FertileChip sperm-selection device, vitrification-based cryopreservation (90-95% post-thaw viability), and the AI-based "Life Whisperer" embryo-selection system. The practice has operated a partnership-based physician model since at least the 1990s and pioneered HyCoSy in Germany in 1995; it currently involves five physician partners and a single Munich site. Marketing and patient acquisition are predominantly organic, via a multilingual website (German, English, Spanish), Facebook, Instagram, downloadable brochures, online patient questionnaires, and gynecologist referrals; no paid acquisition or multi-site footprint is indicated.
The revenue model is a direct-to-consumer professional-services model with per-procedure and per-cycle billing. GKV covers 50% of IVF/ICSI and IUI costs for eligible married heterosexual couples (woman age 25-39, man age 25-50, max 3 treatments per insurance cycle), PKV typically covers full costs, and uninsured or ineligible patients (lesbian couples, single women, patients outside age criteria) bear full costs, with a first blood draw priced at approximately EUR 600 and initial consultations around EUR 165. The practice has also begun an employer-side "Fertility Benefits" consulting stream, and routes patients requiring donor sperm to partner sperm banks (Cryos, European Sperm Bank) and to a specialist fertility lawyer for SaRegG-compliant legal consultation. No revenue, headcount, or growth figures are publicly disclosed.
Kinderwunsch und Hormon Zentrum an der Oper firmographics
Firmographics- Name
- Kinderwunsch und Hormon Zentrum an der Oper
- Legal name
- Lacher Puchta Pauer Michna PartG
- Website
- https://kinderwunschzentrum-an-der-oper.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Kinderwunsch und Hormon Zentrum an der Oper is a private Munich fertility clinic operated as a five-physician partnership, offering diagnostics, IVF, ICSI, IUI, social freezing, and AI-assisted embryo selection to heterosexual couples, lesbian couples, and single women under GKV, PKV, and self-pay models.
- Ownership category
- akta.pro rank
Kinderwunsch und Hormon Zentrum an der Oper industry classification
Industry- Product category
- Reproductive Medicine / Fertility Treatment Services
- NAICS
- Family Planning Centers (62141)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
Keywords
Where Kinderwunsch und Hormon Zentrum an der Oper is headquartered
LocationHeadquarters
- HQ city
- Munich
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Kinderwunsch und Hormon Zentrum an der Oper business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- IVF and ICSI Treatment: In-vitro fertilization and intracytoplasmic sperm injection procedures. Government health insurance (GKV) covers 50% of costs for eligible married heterosexual couples meeting age criteria (woman 25-39, man 25-50). Private insurance typically covers full costs.
- Insemination (IUI): Intrauterine insemination procedure, the most natural and cost-effective fertility treatment. Covered partially by statutory insurance for eligible couples.
- Diagnostic Services: Blood analysis, hormone diagnostics, spermiogram, and HyCoSy tubal patency testing performed in in-house laboratory. Initial blood draw costs approximately EUR 600 for patients not meeting statutory insurance criteria.
- Social Freezing / Egg Cryopreservation: Elective egg freezing services including vitrification and storage for women wishing to preserve fertility for future family planning.
- Natural Messenger Substance Therapy: Hormone optimization therapy using natural messenger substances to stimulate ovulation and corpus luteum function without additional hormone injections, improving natural pregnancy rates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | First Diagnostic Blood Draw (Self-Pay / Ineligible Patients) |
| One time/ perpetual license | Pay-as-you-go | Initial Consultation Cost (Non-Eligible Patients) |
| Subscription | Multi-year contract | IVF/ICSI Treatment (50% GKV Coverage) |
| One time/ perpetual license | Pay-as-you-go | Lesbian Couples / Single Women (Self-Pay) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Kinderwunsch und Hormon Zentrum an der Oper product offering
Product offeringCore offering
Kinderwunsch und Hormon Zentrum an der Oper is a Munich-based fertility center that provides comprehensive reproductive medicine services including fertility diagnostics (hormone analysis, AMH testing, spermiogram, HyCoSy tubal patency testing), consultation, and a full range of assisted reproductive treatments — natural messenger substance therapy, intrauterine insemination (IUI), in-vitro fertilization (IVF), and intracytoplasmic sperm injection (ICSI) — supported by advanced laboratory technologies (EmbryoScope, FertileChip, vitrification, KI Life Whisperer AI). The center also offers social freezing/egg cryopreservation and employer-sponsored fertility benefits consulting, serving heterosexual couples, lesbian couples, and single women under public (GKV), private (PKV), and self-pay arrangements.
Product overview
Kinderwunsch und Hormon Zentrum an der Oper is a fertility center offering a comprehensive portfolio of diagnostic and treatment services. The core offering includes fertility diagnostics (hormone testing, AMH-check, spermiogram, HyCoSy tubal patency testing), consultation services, and multiple treatment modalities: natural messenger substance therapy, intrauterine insemination (IUI), IVF, and ICSI. Advanced technologies include the EmbryoScope® (time-lapse embryo monitoring incubator), Fertile®Chip (sperm selection chip), KI Life Whisperer (AI-based embryo selection), and Assisted Hatching. The center also provides social freezing/egg cryopreservation using vitrification technology, cryopreservation services, and employer fertility benefits consulting. Treatment for heterosexual couples, lesbian couples, and single women is available.
Differentiator
Problem solved
Functional benefit
Products and services
- Kinderwunsch-Beratung (Fertility Consultation) Comprehensive fertility counseling and consultation services addressing patient concerns about difficulty conceiving, including guidance on treatment options, probabilities, risks, and costs.
Quantifiable outcome
- IVF pregnancy success rate of 40-50% per embryo transfer
- +3 more outcomes
Companies that use Kinderwunsch und Hormon Zentrum an der Oper
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
Kinderwunsch und Hormon Zentrum an der Oper technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Kinderwunsch und Hormon Zentrum an der Oper partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- Nina Angerbauer (Specialist Lawyer, ALHR)minorFertility law specialist providing mandatory legal consultation for lesbian couples and single women before fertility treatment, as required under the German Sperm Donor Registry Act (SaRegG) effective July 21, 2017. The practice has a dedicated email address for coordinating appointments: [email protected].
- Cryos International Sperm BankminorRecommended professional sperm bank for donor sperm. Patients create accounts, select donors (non-anonymous per German law, DE-standard), and order MOT 20 for IUI/IVF or MOT 10/5 for ICSI. Practice provides ordering guidance and delivery address for Munich clinic.
- European Sperm BankminorAlternative recommended professional sperm bank for donor sperm procurement. Same donor selection criteria apply (non-anonymous, DE-standard). Used as option alongside Cryos for patients requiring donor sperm.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Kinderwunsch und Hormon Zentrum an der Oper competitors and assessment
Company assessmentBroad incumbents
- IVI-RMA Global: Largest global fertility clinic network with extensive IVF/ICSI capabilities across Europe. Comparable as a multi-site reproductive medicine provider operating at higher scale and offering the same core treatments (IVF, ICSI, IUI, egg freezing) with advanced lab technology.
- Shady Grove Fertility: Large US fertility network with employer-benefit partnerships and shared-risk programs. Comparable in operating model as a fertility clinic network serving insured and self-pay patients with employer-sponsored benefit offerings.
Emerging players
- Carrot Fertility: Global fertility benefits platform partnering with employers and clinics. Comparable as an emerging player in the employer-sponsored fertility benefits category that this clinic has begun to address with its Fertility Benefits service.
- Maven Clinic: Digital women's and family health platform with employer benefits including fertility. Comparable as a technology-driven entrant addressing employer fertility benefits and digital patient engagement, contrasting with this clinic's in-person delivery model.
Direct peers
- VivaNeo (TFP): European fertility clinic network with multiple German sites offering IVF, ICSI, social freezing, and hormone diagnostics. Directly comparable as a competing German fertility clinic group targeting the same statutory/private insurance and self-pay patients.
- CCRM (Colorado Center for Reproductive Medicine): US fertility clinic group known for advanced reproductive technology including proprietary lab methods and high IVF success rates. Comparable as a technology-forward fertility practice emphasizing clinical outcomes and innovation.
- Boston IVF: Established US fertility practice network offering IVF, ICSI, egg freezing, and fertility diagnostics. Comparable as a multi-physician fertility group with similar service breadth including reproductive endocrinology and male factor treatment.
- New Hope Fertility Center: Fertility clinic known for technology-led IVF and natural/minimal-stimulation protocols. Comparable as an innovation-oriented fertility practice emphasizing lab technology (e.g., EmbryoScope-class incubation) and patient-friendly protocols.
Others
- Cryos International: International sperm bank recommended by the clinic for donor sperm procurement. Comparable as a supplier within the same patient treatment workflows rather than a clinical competitor.
- European Sperm Bank: Donor sperm supplier recommended by the clinic for lesbian couples and single women. Comparable as an ecosystem partner in the fertility treatment supply chain rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Kinderwunsch und Hormon Zentrum an der Oper social profiles
Digital presenceKinderwunsch und Hormon Zentrum an der Oper financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kinderwunsch und Hormon Zentrum an der Oper leadership team
Management profileNumber of profiles
Profiles6 records
Kinderwunsch und Hormon Zentrum an der Oper funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kinderwunsch und Hormon Zentrum an der Oper M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kinderwunsch und Hormon Zentrum an der Oper
What does Kinderwunsch und Hormon Zentrum an der Oper do?
Kinderwunsch und Hormon Zentrum an der Oper is a Munich-based fertility center that provides comprehensive reproductive medicine services including fertility diagnostics (hormone analysis, AMH testing, spermiogram, HyCoSy tubal patency testing), consultation, and a full range of assisted reproductive treatments — natural messenger substance therapy, intrauterine insemination (IUI), in-vitro fertilization (IVF), and intracytoplasmic sperm injection (ICSI) — supported by advanced laboratory technologies (EmbryoScope, FertileChip, vitrification, KI Life Whisperer AI). The center also offers social freezing/egg cryopreservation and employer-sponsored fertility benefits consulting, serving heterosexual couples, lesbian couples, and single women under public (GKV), private (PKV), and self-pay arrangements.
Is Kinderwunsch und Hormon Zentrum an der Oper a public or private company?
Kinderwunsch und Hormon Zentrum an der Oper is a private company. It is classified as management employee owned and is currently operating.
When was Kinderwunsch und Hormon Zentrum an der Oper founded?
Kinderwunsch und Hormon Zentrum an der Oper was founded in -1. It employs 1 to 10 people.
Where is Kinderwunsch und Hormon Zentrum an der Oper based?
Kinderwunsch und Hormon Zentrum an der Oper is headquartered in Munich, Germany, in the Europe region.
How does Kinderwunsch und Hormon Zentrum an der Oper make money?
Five revenue lines are on record. IVF and ICSI Treatment is the primary driver. The others are insemination (IUI), diagnostic Services, social Freezing / Egg Cryopreservation and natural Messenger Substance Therapy.
Who are Kinderwunsch und Hormon Zentrum an der Oper's main competitors?
Broad incumbents on record are IVI-RMA Global and Shady Grove Fertility. Emerging players are Carrot Fertility and Maven Clinic. Direct peers are VivaNeo (TFP), CCRM (Colorado Center for Reproductive Medicine), Boston IVF and New Hope Fertility Center. Others are Cryos International and European Sperm Bank.
Does Kinderwunsch und Hormon Zentrum an der Oper have an API?
No public API is recorded for Kinderwunsch und Hormon Zentrum an der Oper.
What industry is Kinderwunsch und Hormon Zentrum an der Oper in?
Kinderwunsch und Hormon Zentrum an der Oper's product category is Reproductive Medicine / Fertility Treatment Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers. Its NAICS code is 62141 and its SIC code is 8011.